IRIS UniCatt

Miele, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.937
NA - Nord America 6.589
AS - Asia 4.338
SA - Sud America 811
AF - Africa 74
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 24
Totale 20.805
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.495
DE - Germania 2.579
IT - Italia 1.828
SG - Singapore 1.682
SE - Svezia 1.569
CN - Cina 1.478
BR - Brasile 740
IE - Irlanda 562
UA - Ucraina 492
FR - Francia 370
ID - Indonesia 365
NL - Olanda 361
GB - Regno Unito 259
FI - Finlandia 253
RU - Federazione Russa 226
IN - India 196
TR - Turchia 163
KR - Corea 150
BE - Belgio 87
HK - Hong Kong 83
PL - Polonia 74
AT - Austria 67
CA - Canada 51
CH - Svizzera 51
IR - Iran 43
CZ - Repubblica Ceca 40
JP - Giappone 31
AU - Australia 25
VN - Vietnam 24
AR - Argentina 23
CI - Costa d'Avorio 21
EU - Europa 19
LT - Lituania 18
ES - Italia 17
MX - Messico 17
PT - Portogallo 16
RO - Romania 15
BD - Bangladesh 14
IQ - Iraq 13
PK - Pakistan 13
CO - Colombia 12
EG - Egitto 11
HU - Ungheria 11
CL - Cile 10
MA - Marocco 10
ZA - Sudafrica 10
GR - Grecia 9
PH - Filippine 9
EC - Ecuador 8
IL - Israele 8
SA - Arabia Saudita 8
AE - Emirati Arabi Uniti 7
NZ - Nuova Zelanda 7
PA - Panama 7
UZ - Uzbekistan 7
AZ - Azerbaigian 6
DK - Danimarca 6
PE - Perù 6
BZ - Belize 5
EE - Estonia 5
KG - Kirghizistan 5
LK - Sri Lanka 5
TN - Tunisia 5
NG - Nigeria 4
PY - Paraguay 4
AL - Albania 3
BO - Bolivia 3
CR - Costa Rica 3
DZ - Algeria 3
GE - Georgia 3
HN - Honduras 3
HR - Croazia 3
KE - Kenya 3
MY - Malesia 3
OM - Oman 3
SC - Seychelles 3
VE - Venezuela 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BY - Bielorussia 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
IS - Islanda 2
JM - Giamaica 2
KH - Cambogia 2
KZ - Kazakistan 2
NO - Norvegia 2
NP - Nepal 2
PR - Porto Rico 2
RE - Reunion 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TW - Taiwan 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
A1 - Anonimo 1
BG - Bulgaria 1
CG - Congo 1
DJ - Gibuti 1
Totale 20.793
Salva come PNG Salva come JPEG
Città #
Chandler 1.092
Singapore 1.003
Dublin 560
Ashburn 545
Jakarta 360
Chicago 328
Rome 289
Jacksonville 287
Milan 277
San Mateo 251
New York 220
Nanjing 204
Hefei 166
Moscow 159
Nürnberg 154
Ann Arbor 153
Wilmington 148
Seoul 146
Boston 144
Los Angeles 143
Helsinki 127
Houston 123
Izmir 123
Munich 117
Marseille 115
Princeton 113
Beijing 112
Dearborn 107
Cattolica 104
The Dalles 103
Brussels 86
Woodbridge 86
Frankfurt am Main 85
Nanchang 77
Seattle 77
Hong Kong 76
Nuremberg 74
Boardman 71
Redmond 55
Hyderabad 51
Kraków 50
Fairfield 49
São Paulo 48
Redwood City 47
Hebei 45
Tianjin 42
Shenyang 41
Zurich 41
Düsseldorf 39
Bremen 38
Lawrence 38
London 37
Zhengzhou 36
Brno 34
Guangzhou 34
Kunming 34
Rio de Janeiro 32
Santa Clara 32
Mountain View 30
Norwalk 30
Changsha 29
San Jose 29
North Bergen 27
Shanghai 26
Vienna 25
Fremont 24
Lauterbourg 24
Hangzhou 23
Pune 23
Jiaxing 22
Toronto 22
University Park 22
Abidjan 21
Belo Horizonte 21
Falkenstein 21
Stockholm 21
Washington 21
Atlanta 20
Palermo 20
San Francisco 20
Amsterdam 19
Paris 19
Trieste 19
Augusta 18
Andover 17
Castelnuovo di Val di Cecina 17
Jinan 17
San Diego 17
Brooklyn 16
Cambridge 16
Kish 16
Leawood 16
Phoenix 16
Portland 16
Tokyo 16
Turku 15
Lancaster 14
Lanzhou 14
Lappeenranta 14
Busto Arsizio 13
Totale 10.074
Salva come PNG Salva come JPEG
Nome #
A multi-society Delphi consensus statement on new fatty liver disease nomenclature 1.064
Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imaging 403
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 221
13C-methionine breath tests for mitochondrial liver function assessment. 215
A phase II study of sunitinib in advanced hepatocellular carcinoma 214
13C-breath tests in the study of microsomal liver function 198
gc) Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. 195
-Hepatic steatosis and vascular disease 180
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 177
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 169
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 167
Severe veno-occlusive disease after autologous peripheral blood stem cell transplantation for high-grade non-Hodgkin lymphoma: report of a successfully managed case and a literature review of veno-occlusive disease. 165
134C-breath tests in the study of mitochondrial liver function 164
Role of diffusion-weighted imaging, apparent diffusion coefficient and correlation with hepatobiliary phase findings in the differentiation of hepatocellular carcinoma from dysplastic nodules in cirrhotic liver 160
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 157
Effect of sildenafil on diabetic gastropathy. 152
Non Alcoholic Fatty Liver Disease is Associated with Increased GHBP and Reduced GH/IGF-I Levels 152
Ethanol injection is highly effective for hepatocellular carcinoma smaller than 2 cm 147
13C-breath tests in the study of microsomial liver function 147
13C-methionine breath tests for mitochondrial liver function assessment 145
Assessment of neurological manifestations in hospitalized patients with COVID-19 137
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 137
Non Alcoholic Fatty Liver Disease is Associated with Increased GHBP and Reduced GH/IGF-I Levels 135
The Effect of CYP, GST, and SULT Polymorphisms and Their Interaction with Smoking on the Risk of Hepatocellular Carcinoma 130
Potential use of liver function breath tests in the clinical practice. 129
[Helicobacter pylori infection: from gastric to systemic disease] 128
[Oxidative stress in metabolic syndrome and nonalcoholic steatohepatitis. Is it possible a role for vitamins in clinical practice?] 127
Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survival 126
gc) Celiac disease in the 21st century: issues of under- and over-diagnosis 124
13C-breath tests in the study of mitochondrial liver function 123
Cryoglobulinemia: a true internistic disease? 122
[The treatment of hepatocellular carcinoma: an update] 120
Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels 117
-Fatty liver and drugs 114
Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). 113
Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome 113
gastroesophageal reflux disease: facts and uncertaines 112
Intrafamilial transmission of hepatitis C virus in Italy: a systematic review 112
Tromboembolism and breast cancer: the hidden risk for patient and physician 112
A case-control study on the effects of the apolipoprotein E genotypes in nonalcoholic fatty liver disease 112
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 109
Cystic lymphangioma of the mesentery and hyposplenism in celiac disease. 108
Liver transplantation in patients with alcoholic liver disease: A retrospective study 108
Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression 108
A case-control study on the effect of metabolic gene polymorphisms, nutrition, and their interaction on the risk of non-alcoholic fatty liver disease 107
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 107
Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease 106
Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre. 105
An Attempt of Specific Desensitizing Treatment with Gliadin in Coleliac Disease 104
Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial 103
Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome 102
High Prevalence and Gender-Related Differences of Gastrointestinal Manifestations in a Cohort of DM1 Patients: A Perspective, Cross-Sectional Study 100
-Nonalcoholic fatty liver disease: defining a common problem 97
Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome 96
Genetic susceptibility of increased intestinal permeability is associated with progressive liver disease and diabetes in patients with non-alcoholic fatty liver disease 96
Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test. 95
Gallstone disease is associated with more severe liver damage in patients with non-alcoholic Fatty liver disease 95
Alcoholic and nonalcoholic forms of fatty liver disease. 94
Autoimmunity and lymphoproliferation markers in naïve HCV-RNA positive patients without clinical evidences of autoimmune/lymphoproliferative disorders 93
Clinical characteristics of metabolic associated fatty liver disease (MAFLD) in subjects with myotonic dystrophy type 1 (DM1) 91
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 87
A case of variant angina in a patient under chronic treatment with sorafenib 86
Gut-liver axis and microbiota in NAFLD: insight pathophysiology for novel therapeutic target 86
Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk 86
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 86
Braised liver with herbs: the risks of naturopathic hepatoprotection. 85
A giant calcified hepatic mass 85
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 85
Socio-demographic determinants of coinfections by HIV, hepatitis B and hepatitis C viruses in central Italian prisoners. 84
Gender affects 13C-ketoisocaproic acid breath test 84
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study 84
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 83
Drug-induced hepatitis 82
Review article: breath testing for human liver function assessment. 82
A case-control study on the effect of metabolic gene polymorphisms, nutrition, and their interaction on the risk of non-alcoholic fatty liver disease 82
Mediterranean diet and the prevention of non-alcoholic fatty liver disease: Results from a case-control study 82
A multi-society Delphi consensus statement on new fatty liver disease nomenclature 81
Is coeliac disease a confounding factor in the diagnosis of NASH? 80
Enhanced liver fibrosis test as a reliable tool for assessing fibrosis in nonalcoholic fatty liver disease in a clinical setting 80
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 80
A novel ABCB11 variant in compound heterozygosity: BRIC2 or PFIC2? 79
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study 77
Different biochemical patterns in type II and type III mixed cryoglobulinemia in HCV positive patients 77
NON ALCOHOLIC STEATOHEPATITIS (NASH) INDUCED BY CARBAMAZEPINE AND VARIEGATE PORPHYRIA 76
A case of esomeprazole-induced transient diabetes and hepatitis: the role of liver inflammation in the pathogenesis of insulin resistance 76
Liver transplantation in alcoholic patients: Impact of an alcohol addiction unit within a liver transplant center 76
Impairment of recent thymic emigrants in HCV infection. 75
Drug-induced liver injury 2017: the diagnosis is not easy but always to keep in mind 75
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: Time for reappraisal of BMI-driven approach? 75
Nutritional aspects in patients with non-alcoholic steatohepatitis (NASH) 74
NAFLD and NASH: behind the fat, there's something more. 74
Gastrointestinal symptoms and digestive comorbidities in an Italian cohort of patients with COVID-19 74
Project for interventional Oncology LArge-database in liveR Hepatocellular carcinoma - Preliminary CT-based radiomic analysis (POLAR Liver 1.1) 74
High efficacy of 1-week doxycycline- and amoxicillin-based quadruple regimen in a culture-guided, third-line treatment approach for Helicobacter pylori infection 73
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 73
FREE LIGHT CHAINS: A NEW POTENTIAL BIOMARKER FOR DISEASE STRATIFICATION IN NON-ALCOHOLIC STEATOHEPATITIS 72
Sporadic HEV hepatitis in Italy. 72
Nonalcoholic fatty liver disease as trigger of cardiovascular and metabolic complication in metabolic syndrome 72
Biology, epidemiology, clinical aspects of hepatocellular carcinoma and the role of Sorafenib 71
Diabetes and Insulin Therapy, but Not Metformin, Are Related to Hepatocellular Cancer Risk 70
Totale 12.214
Salva come PNG Salva come JPEG
Categoria #
all - tutte 115.474
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 115.474
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020126 0 0 0 0 0 0 0 0 0 0 0 126
2020/20211.172 61 116 54 123 156 52 127 21 151 67 218 26
2021/20221.565 46 112 49 178 111 35 24 235 57 98 295 325
2022/20234.189 436 420 240 452 424 566 283 334 448 271 237 78
2023/20243.093 238 800 109 176 159 337 222 106 45 216 266 419
2024/20256.526 151 124 527 243 551 304 319 620 1.308 718 1.507 154
Totale 21.196